OTCMKTS:HRIBF - Horiba Stock Price, News, & Analysis

HORIBA, Ltd. provides a range of instruments and systems for automotive research and development (R&D), process and environmental monitoring, in-vitro medical diagnostics, semiconductor manufacturing, metrology, and scientific R&D and QC measurement applications. Its Automotive Test Systems segment offers emission measurement systems, in-use automotive emissions analyzers, driveline test systems, engine test and brake test systems, and intelligent transport systems; and provides engineering consultancy, test services and consultancy, and research and development facility leasing services. The company's Process & Environmental Instruments & Systems segment provides stack gas analyzers, water quality analysis and examination systems, air pollution analyzers, environmental radiation monitors, and process measurement equipment. Its Medical-Diagnostic Instruments & Systems segment designs, develops, and distributes hematology analyzers, equipment for measuring immunological responses, clinical chemistry analyzers, and blood sugar measurement systems. The company's Semiconductor Instruments & Systems segment provides mass flow controllers, chemical concentration monitors, reticle/mask particle detection systems, and residual gas analyzers. Its Scientific Instruments & Systems segment offers pH meters, particle-size distribution analyzers, X-Ray fluorescence analyzers, metal analyzers, Raman fluorescence spectroscopy systems, spectrophotometers, and gratings. HORIBA, Ltd. was founded in 1945 and is headquartered in Kyoto, Japan.

Horiba (OTCMKTS:HRIBF) Frequently Asked Questions

What is Horiba's stock symbol?

Horiba trades on the OTCMKTS under the ticker symbol "HRIBF."

Has Horiba been receiving favorable news coverage?

Headlines about HRIBF stock have trended somewhat negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Horiba earned a coverage optimism score of -1.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the near term.

Who are some of Horiba's key competitors?

Some companies that are related to Horiba include Bruker (BRKR), Coherent (COHR), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Quanterix (QTRX), Eyepoint Pharmaceuticals (EYPT), Harvard Bioscience (HBIO), Arrayit (ARYC), HTG Molecular Diagnostics (HTGM), BioNano Genomics (BNGO), Aethlon Medical (AEMD), Scientific Industries (SCND), Pressure Biosciences (PBIO) and Precipio (PRPO).

Who are Horiba's key executives?

Horiba's management team includes the folowing people:

• Mr. Atsushi Horiba, Chairman & Group CEO (Age 71)
• Mr. Juichi Saito, Exec. Vice Chairman & Group COO (Age 61)
• Dr. Masayuki Adachi, Pres, COO & Director
• Mr. Sunao Kikkawa, Sr. Corp. Officer and Gen. Mang. of Fin. & Control Division
• Masao Okawa, Sr. Corp. Officer and Gen. Mang. of Gen. Admin. Division

How do I buy shares of Horiba?

Shares of HRIBF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Horiba's stock price today?

One share of HRIBF stock can currently be purchased for approximately $53.15.

How big of a company is Horiba?

Horiba has a market capitalization of $2.24 billion and generates $1.57 billion in revenue each year.